Morin ameliorates methotrexate-induced hepatotoxicity via targeting Nrf2/HO-1 and Bax/Bcl2/Caspase-3 signaling pathways

Hamit Emre Kızıl,Cuneyt Caglayan,Ekrem Darendelioğlu,Adnan Ayna,Cihan Gür,Fatih Mehmet Kandemir,Sefa Küçükler
DOI: https://doi.org/10.1007/s11033-023-08286-8
IF: 2.7422
2023-02-16
Molecular Biology Reports
Abstract:Organ toxicity limits the therapeutic efficacy of methotrexate (MTX), an anti-metabolite therapeutic that is frequently used as an anti-cancer and immunosuppressive medicine. Hepatocellular toxicity is among the most severe side effects of long-term MTX use. The present study unveils new confirmations as regards the remedial effects of morin on MTX-induced hepatocellular injury through regulation of oxidative stress, apoptosis and MAPK signaling.
biochemistry & molecular biology
What problem does this paper attempt to address?